Two such disorders are GBA-associated Parkinson’s disease (GBA-PD) and progranulin-associated frontotemporal dementia (GRN-FTD), both of which are associated with the heterozygous loss of function of a lysosomal protein (beta glucocerebrosidase and progranulin, respectively). This evidence concerns the gene GBA1 and Parkinson disease.